Join us for Breakfast at King's - a series of discussions with experts at King's College London, hosted by Prof. James Galloway, on recent updates across the field of rheumatology!

In this episode, Dr Mark Russell discusses two recent papers looking at the use of colchicine prophylaxis for patients with gout when starting or escalating allopurinol doses. Dr Russell weighs up the benefits and risks of colchicine use, and discusses its potential in gout flare management.

Join us for Breakfast at King's hosted by Prof. James Galloway, a video series featuring updates in rheumatology with experts at King's College London.

In this episode, Dr Andrew Rutherford discusses the management of patients with rheumatoid arthritis and antidrug antibodies, who are being treated with biologics, including which biologic drugs have the highest risk of antidrug antibodies and whether methotrexate can reduce this risk.

Join us for Breakfast at King's - a series of discussions with experts at King's College London, hosted by Prof. James Galloway, on recent updates across the field of rheumatology!

In this episode, Dr Chris Wincup discusses a published case series that highlights the potential for CAR T-cell therapy for patients with autoimmune disease. He also describes the long and durable responses being seen with CAR-T cell therapy, hospitalisation requirements for those undergoing therapy, and specific safety considerations (including CRS and ICANS).

In this final episode of our CAR-T update series, Dr Robin Sanderson, consultant haematologist at Kings College Hospital in London, talks about the efficacy and toxicity data presented at US and European meetings this year. As more real-world evidence is gathered, how is this moving the therapy forward.

In the second of three episodes, Dr Graham Collins, consultant haematologist in Oxford, discusses how they prepared to infuse their first patient and what is happening with the wider rollout of CAR T therapies to other NHS centres.

In this first episode, Dr Maeve O’Reilly, a consultant haematologist at University College Hospital London, takes us through new approvals and indications of CAR T and what to expect next.

Sarah Henshaw, myeloma clinical nurse specialist at Nottingham University Hospitals and Dr Jennifer Vidrine, consultant in palliative and supportive care medicine at Newcastle Hospitals NHS Foundation Trust discuss what psychosocial support patients may need at different points in their care, advance care planning, when to refer to palliative care teams and how teams can best work together in the interest of the patient.

Professor Gordon Cook, professor of haematology at the University of Leeds and lead for the myeloma clinical and translational research portfolio and Professor Graham Jackson, consultant haematologist at Newcastle upon Tyne Hospitals NHS Foundation Trust discuss managing toxicities associated with treatment including peripheral neuropathies, cytopenias, cytokine release syndrome and ICANs, as well as cardiac and gastrointestinal complications.

Professor Gordon Cook, professor of haematology at the University of Leeds and lead for the myeloma clinical and translational research portfolio and Professor Graham Jackson, consultant haematologist at Newcastle upon Tyne Hospitals NHS Foundation Trust discuss managing and preventing infection in blood cancer patients, including prophylaxis, vaccination, Covid and more.

Michelle Kenyon, consultant nurse in BMT at Kings College Hospital NHS Foundation Trust, and Dr Stella Bowcock, consultant haematologist interested in myeloma and supportive care, also based at Kings College Hospital NHS Foundation Trust, discuss the pillars of supportive care in haematology-oncology, what is unique about the needs of this group of patients, communication and co-ordination of care throughout the patient journey.